GlaxoSmithKline PLC (OTCQB:GLAXF)

Data as of 3:50pm ET
 -0.07 / -0.29%
Today’s Change
Today|||52-Week Range
Novartis Division Gets European Approval for Simbrinza - Analyst Blog
7:13pm /
Two Giants Blindsided by Major Trends
Jul 23 /
Markets Little Changed Ahead Of The Federal Reserve's Policy Decision
5:53pm / Benzinga
Why GlaxoSmithKline (GSK) Stock Continues To Sink Today
Jul 23 /
What Makes Johnson & Johnson a Healthy Dividend Investment
2:55pm /
Puma Shares Soar When Wall Street Misplays Expectation Game
Jul 23 /
Why GlaxoSmithKline (GSK) Stock Is Higher Today
8:50am /
Why GlaxoSmithKline (GSK) Stock Is Falling Today
Jul 23 /
GlaxoSmithKline, plc (GSK): New Analyst Report from Zacks Equity Research - Zacks Equ...
Jul 25 /
Heavy Volume And Pre-Market Movement For GlaxoSmithKline (GSK)
Jul 23 /
Why GlaxoSmithKline (GSK) Stock Is Lower Today
Jul 25 /
What To Buy: Top 3 Buy-Rated Dividend Stocks: STWD, ESV, GSK
Jul 22 /
GlaxoSmithKline (GSK) Weak In Early Morning Trading
Jul 25 /
Here's What You Need to Know About AbbVie and GlaxoSmithKline's Upcoming Earnings
Jul 22 /
Today's Top Health Care Headlines: AbbVie and GlaxoSmithKline
Jul 25 /
Isis Pharma Initiates Phase II Study on ISIS-APO(a) - Analyst Blog
Jul 21 /
UCB's Brivaracetam Positive in Phase III Epilepsy Study - Analyst Blog
Jul 24 /
Novartis Misses on Q2 Earnings & Revenue, Outlook Retained - Analyst Blog
Jul 18 /
Were There Any Silver Linings in GlaxoSmithKline Stock's Earnings Failure?
Jul 24 /
Today's Top Health Care Stocks to Watch: AbbVie, GlaxoSmithKline, and Shire
Jul 17 /
Pharma, Biotech M&As Heat Up: Tax Inversion in Focus - Zacks Analyst Interviews
Jul 24 /
Theravance/Glaxo Commence Global Late stage Study on COPD - Analyst Blog
Jul 16 /
Pharma, Biotech M&As Heat Up: Tax Inversion in Focus - Industry Outlook
Jul 24 /
Roche Gets Priority Review for Avastin Label Expansion - Analyst Blog
Jul 16 /
3 Game-Changing Stories That Shook Investors: Inovio Pharmaceuticals, Gilead Sciences...
Jul 24 /
Should Roche Buy Exelixis?
Jul 16 /
Glaxo (GSK) Slips on Disappointing Q2 Earnings, Cuts View - Analyst Blog
Jul 24 /
Time to Fall Back in Love With Exelixis Inc.?
Jul 15 /
Zacks Rank #5 Additions for Thursday - Tale of the Tape
Jul 24 /
China targets Apple for location-tracking apps
Jul 11 /
What Will Puma Biotechnology Inc's $700 Million Man Do Next?
Jul 23 /

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.